J&J’s Cerenovus Launched Next-Gen Stroke Revascularization Catheter
On February 7, 2024, Johnson & Johnson MedTech’s Cerenovus announced the launch of its next-generation CereGlide 71 intermediate catheter with TruCourse indicated for the revascularization of patients suffering from acute ischemic stroke.
It expands the portfolio of Cerenovus Stroke Solutions by joining the CereGlide family of catheters, which the business plans to launch. According to the business, the system has been tuned for both the delivery of compatible stent retrievers and for efficient direct aspiration. This contains the neurovasculature's EmboTrap III revascularization d...